POC Diagnostics Market Size, Share Global Analysis Report, 2020–2026

Industry Insights

[190+ Pages Report] According to the report published by Facts Factors, the global POC diagnostics market size was worth around USD xx million/billion in 2019 and is predicted to grow to around USD xx million/billion by 2026 with a compound annual growth rate (CAGR) of roughly xx% between 2020 and 2026. The report analyzes the global POC diagnostics market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the POC diagnostics market.

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the POC diagnostics industry. The report analyzes and declares the historical and current trends analysis of the POC diagnostics industry and subsequently recommends the projected trends anticipated to be observed in the POC diagnostics market during the upcoming years.

The POC diagnostics market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire POC diagnostics market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

Key Insights from Primary Research

• As per our major research, the POC diagnostics market is set to grow annually at a rate of around 7%
• It was established through main research that the POC diagnostics market was valued at around USD 740 Million in 2019
• Based on product type segmentation, the “HIV POC” category accounting for around 24% share, in 2019
• Based on end-user segmentation, the “Hospital” category held the leading share at more than 69%, in 2019
• In terms of product type HIV contributed the major market shares in terms of revenue due to its increasing incidences in South Africa and wide acceptance coupled with awareness across the European & African region.

Key Recommendations from Analysts

• As per our analysts, Europe market is estimated to grow at a CAGR of 4% during 2019-2026
•  Europe region growth is mainly driven by countries like Germany, France, UK, and others
• Germany market accounted for a major revenue share of USD 108% Million in 2019 and continues to lead the POC Diagnostics market.
• This industry is a steadily rising industry, and the degree of increasing consumption will show a smooth growth curve.
• POC diagnostics the major part of manufacturing cost is attributed to the monthly wages/salary of labor and raw material sourcing.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the POC Diagnostics industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the POC Diagnostics industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the POC diagnostics market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the POC diagnostics industry. The POC diagnostics market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the POC dagnostics sector. Key strategic developments in the POC Diagnostics market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the POC Diagnostics market are appropriately highlighted in the report.

POC diagnostics are implemented at and nearby the place anywhere a patient originally encounters the health care system. Point of care diagnostics lets medical staff and physicians to exactly succeed actual, lab-quality diagnostic effects inside minutes slightly hours. Equally, healthcare starts to move to customers, the demand for checks that can be completed wherever the patient is placed.

Better-quality patient effects, the directly obtainability of test effects can be connected to the patient organization to simplify the effort of separate patients concluded the organization faster and let used for the treatment of additional patients in a reduced time frame.

The POC diagnostics market research report delivers an acute valuation and taxonomy of the POC diagnostics industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026.

Report Scope

The regional segmentation of the POC diagnostics industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the POC diagnostics industry is provided for the leading economies of the world.

The POC diagnostics market is segmented based on product and end-user. On the basis of product segmentation, the market is classified into hsTnI, BNP and NT-ProBNP, HbA1c, PCT, TSH & FT4, HIV POC, and Influenza POC. In terms of end-user segmentation, the market is bifurcated into Hospital, Home & Healthcare Centers, ACAD, Others.

Some of the essential players operating in the POC Diagnostics market, but not restricted to include

•  F. Hoffmann-La Roche Ltd.
•  Danaher Corporation
•  Abbott Laboratories
•  bioMérieux SA
•  Nova Biomedical
•  Becton Dickinson & Company
•  Siemens Healthcare GmbH
•  Trividia Health Inc.
•  QIAGEN
•  Sekisui Diagnostics LLC
•  Quidel Corporation

The taxonomy of the POC diagnostics industry by its scope and segmentation is as follows:

By Product Segmentation Analysis 

• hsTnI
• BNP and NT-ProBNP
• HbA1c
• PCT
• TSH & FT4
• HIV POC
• Influenza POC

By End User Segmentation Analysis

• Hospital
• Home & Healthcare Centers
• ACAD
• Others

By Regional Segmentation Analysis

• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa